203 related articles for article (PubMed ID: 26442919)
1. New Pointers for Surgical Staging of Borderline Ovarian Tumors.
Bendifallah S; Nikpayam M; Ballester M; Uzan C; Fauvet R; Morice P; Darai E
Ann Surg Oncol; 2016 Feb; 23(2):443-9. PubMed ID: 26442919
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of microinvasion in borderline ovarian tumors and its impact on surgical management.
Ferrero A; Strada I; Di Marcoberardino B; Maccarini LR; Pozzati F; Rossi M; Biglia N; De Iaco P
Int J Gynecol Cancer; 2012 Sep; 22(7):1158-62. PubMed ID: 22801031
[TBL] [Abstract][Full Text] [Related]
3. Prognosis in patients with serous and mucinous stage I borderline ovarian tumors.
Song T; Lee YY; Choi CH; Kim TJ; Lee JW; Kim BG; Bae DS
Int J Gynecol Cancer; 2012 Jun; 22(5):770-7. PubMed ID: 22426410
[TBL] [Abstract][Full Text] [Related]
4. Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation.
Fotopoulou C; Zang R; Gultekin M; Cibula D; Ayhan A; Liu D; Richter R; Braicu I; Mahner S; Harter P; Trillsch F; Kumar S; Peiretti M; Dowdy SC; Maggioni A; Trope C; Sehouli J
Ann Surg Oncol; 2013 Apr; 20(4):1348-54. PubMed ID: 23054114
[TBL] [Abstract][Full Text] [Related]
5. The value of random biopsies, omentectomy, and hysterectomy in operations for borderline ovarian tumors.
Kristensen GS; Schledermann D; Mogensen O; Jochumsen KM
Int J Gynecol Cancer; 2014 Jun; 24(5):874-9. PubMed ID: 24844221
[TBL] [Abstract][Full Text] [Related]
6. High-risk borderline ovarian tumors: analysis of clinicopathological features and prognostic impact of different follow-up strategies.
Lorusso D; Ratti M; Ditto A; Raspagliesi F
Oncology; 2014; 87(3):183-92. PubMed ID: 25033912
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of borderline ovarian tumors clinical outcome and prognostic factors.
Lazarou A; Fotopoulou C; Coumbos A; Sehouli J; Vasiljeva J; Braicu I; Burger H; Kuehn W
Anticancer Res; 2014 Nov; 34(11):6725-30. PubMed ID: 25368281
[TBL] [Abstract][Full Text] [Related]
8. Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor.
Romeo M; Pons F; Barretina P; Radua J
World J Surg Oncol; 2013 Jan; 11():13. PubMed ID: 23343188
[TBL] [Abstract][Full Text] [Related]
9. The role of omentectomy and random peritoneal biopsies as part of comprehensive surgical staging in apparent early-stage epithelial ovarian cancer.
Lee JY; Kim HS; Chung HH; Kim JW; Park NH; Song YS
Ann Surg Oncol; 2014 Aug; 21(8):2762-6. PubMed ID: 24770785
[TBL] [Abstract][Full Text] [Related]
10. Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre.
Anfinan N; Sait K; Ghatage P; Nation J; Chu P
Arch Gynecol Obstet; 2011 Sep; 284(3):731-5. PubMed ID: 20963432
[TBL] [Abstract][Full Text] [Related]
11. Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study.
Ditto A; Martinelli F; Reato C; Kusamura S; Solima E; Fontanelli R; Haeusler E; Raspagliesi F
Ann Surg Oncol; 2012 Nov; 19(12):3849-55. PubMed ID: 22707110
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.
Bagnoli M; Canevari S; Califano D; Losito S; Maio MD; Raspagliesi F; Carcangiu ML; Toffoli G; Cecchin E; Sorio R; Canzonieri V; Russo D; Scognamiglio G; Chiappetta G; Baldassarre G; Lorusso D; Scambia G; Zannoni GF; Savarese A; Carosi M; Scollo P; Breda E; Murgia V; Perrone F; Pignata S; De Cecco L; Mezzanzanica D;
Lancet Oncol; 2016 Aug; 17(8):1137-1146. PubMed ID: 27402147
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic analysis of 130 cases of mucinous borderline ovarian tumors].
Cao DY; Shen K; Tao T; Yang JX; Xiang Y; Huang HF; Wu M; Pan LY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):15-8. PubMed ID: 21429428
[TBL] [Abstract][Full Text] [Related]
14. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
15. Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors.
Vancraeynest E; Moerman P; Leunen K; Amant F; Neven P; Vergote I
Int J Gynecol Cancer; 2016 Oct; 26(8):1399-406. PubMed ID: 27465897
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic features of 234 cases with borderline ovarian tumors].
Ren J; Lou JY; Liu H; Wang P; Zhang JW; Yang KX; Wang HJ; Qie MR; Peng ZL
Zhonghua Fu Chan Ke Za Zhi; 2009 Feb; 44(2):116-20. PubMed ID: 19570422
[TBL] [Abstract][Full Text] [Related]
17. The Factors Predicting Recurrence in Patients With Serous Borderline Ovarian Tumor.
Ureyen I; Karalok A; Tasci T; Turkmen O; Boran N; Tulunay G; Turan T
Int J Gynecol Cancer; 2016 Jan; 26(1):66-72. PubMed ID: 26512785
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Surgical Staging on the Prognosis of Mucinous Borderline Tumors of the Ovaries: A Multicenter Study.
Gungorduk K; Asicioglu O; Braicu EI; Almuheimid J; Gokulu SG; Cetinkaya N; Gungor T; Pakay G; Telli EU; Cuylan ZF; Toptas T; Bilgi A; Ozyurt R; Agacayak E; Ozdemir A; Yildirim N; Taskin S; Oge T; Erol O; Akman L; Turan A; Icen MS; Senol T; Ovali OI; Yucesoy B; Gungorduk O; Temizkan O; Sanci M; Simsek T; Meydanli MM; Harma M; Yasar L; Uysal AD; Karateke A; Ortac F; Ozalp SS; Sehouli J; Muallem MZ
Anticancer Res; 2017 Oct; 37(10):5609-5616. PubMed ID: 28982877
[TBL] [Abstract][Full Text] [Related]
19. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
[TBL] [Abstract][Full Text] [Related]
20. Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer--A Single Center Experience.
Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
Anticancer Res; 2015 Oct; 35(10):5649-54. PubMed ID: 26408738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
